Justices Told To Undo 'Impossible' Patent Enablement Rules
GlaxoSmithKline and a group of law professors urged the U.S. Supreme Court on Wednesday to throw out a Federal Circuit decision invalidating two Amgen cholesterol drug patents, saying it set patent...To view the full article, register now.
Already a subscriber? Click here to view full article